当前位置: X-MOL 学术J. Natl. Cancer Inst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
Journal of the National Cancer Institute ( IF 10.3 ) Pub Date : 2017-11-18 , DOI: 10.1093/jnci/djx227
Yueye Huang 1, 2 , Shen Qu 2 , Guangwu Zhu 1 , Fei Wang 1 , Rengyun Liu 1 , Xiaopei Shen 1 , David Viola 3 , Rossella Elisei 3 , Efisio Puxeddu 4 , Laura Fugazzola 5 , Carla Colombo 5 , Barbara Jarzab 6 , Agnieszka Czarniecka 6 , Alfred K Lam 7 , Caterina Mian 8 , Federica Vianello 9 , Linwah Yip 10 , Garcilaso Riesco-Eizaguirre 11, 12, 13 , Pilar Santisteban 12, 13 , Christine J O’Neill 14 , Mark S Sywak 14 , Roderick Clifton-Bligh 14 , Bela Bendlova 15 , Vlasta Sýkorová 15 , Mingzhao Xing 1
Affiliation  

Precise risk stratification-based treatment of solitary intrathyroidal papillary thyroid cancer (SI-PTC) that is larger than 1.0 cm and 4.0 cm or less is undefined.

中文翻译:

单独治疗的BRAF V600E突变辅助的危险性分层可单独治疗甲状腺内乳头状甲状腺癌

尚不确定基于危险分层的单独的大于1.0 cm小于等于4.0 cm的甲状腺内乳头状甲状腺癌(SI-PTC)的治疗方法。
更新日期:2018-04-09
down
wechat
bug